Antineoplastic Drug-Induced Cardiotoxicity: A Redox PerspectiveGilda Varricchi, Carlo G. Tocchetti, Giuseppe Mercuro et al.|Frontiers in Physiology|2018Cited by 154
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational OverviewCarlo G. Tocchetti, Giuseppe Mercuro, Christian Cadeddu Dessalvi et al.|Antioxidants and Redox Signaling|2017Cited by 122
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyondDaniela Di Lisi, Giuseppina Novo, Rosalinda Madonna et al.|International Journal of Cardiology|2016Cited by 73
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogensChristian Cadeddu Dessalvi, Giuseppe Mercuro, Alessia Pepe et al.|Heart Failure Reviews|2019Cited by 55
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicityPaolo Spallarossa, Giuseppe Mercuro, Nicola Maurea et al.|Journal of Cardiovascular Medicine|2016Cited by 52